Vimovo
These highlights do not include all the information needed to use VIMOVO safely and effectively. See full prescribing information for VIMOVO. VIMOVO (naproxen and esomeprazole magnesium) delayed-release tablets, for oral use Initial U.S. Approval: 2010
baa47781-7151-4c75-a9a2-d2eac0a7d55e
HUMAN PRESCRIPTION DRUG LABEL
Jul 25, 2023
Horizon Therapeutics USA, Inc.
DUNS: 033470838
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Naproxen and Esomeprazole Magnesium
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (20)
Naproxen and Esomeprazole Magnesium
Product Details
FDA regulatory identification and product classification information